We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.45B
AUM Growth
+$44.4M
Cap. Flow
-$94.4M
Cap. Flow %
-3.85%
Top 10 Hldgs %
40.67%
Holding
310
New
32
Increased
52
Reduced
85
Closed
39

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.4M
2
LVS icon
Las Vegas Sands
LVS
+$21.8M
3
META icon
Meta Platforms (Facebook)
META
+$21.8M
4
XOM icon
ExxonMobil
XOM
+$18.7M
5
NOW icon
ServiceNow
NOW
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 35.89%
2 Healthcare 15.81%
3 Industrials 10.04%
4 Consumer Discretionary 8.44%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBER icon
51
Uber
UBER
$145B
$8.54M 0.35%
117,490
KD icon
52
Kyndryl
KD
$3.09B
$8.51M 0.35%
323,570
+11,440
+4% +$274K
CRS icon
53
Carpenter Technology
CRS
$26.4B
$8.48M 0.35%
77,430
+6,200
+9% +$596K
MTSI icon
54
MACOM Technology Solutions
MTSI
$17.4B
$8.44M 0.34%
75,740
+8,430
+13% +$859K
ESI icon
55
Element Solutions
ESI
$8.48B
$8.36M 0.34%
308,290
+22,240
+8% +$548K
XPO icon
56
XPO
XPO
$23.4B
$8.32M 0.34%
78,344
-660
-0.8% -$74K
SAIA icon
57
Saia
SAIA
$10.5B
$8.28M 0.34%
17,460
-150
-0.9% -$69.9K
NTRA icon
58
Natera
NTRA
$36.4B
$8.01M 0.33%
74,000
-630
-0.8% -$64K
TWST icon
59
Twist Bioscience
TWST
$5.32B
$7.76M 0.32%
157,380
+10,750
+7% +$438K
HQY icon
60
HealthEquity
HQY
$8.71B
$7.74M 0.32%
89,800
-780
-0.9% -$63K
APPF icon
61
AppFolio
APPF
$6.62B
$7.73M 0.32%
31,600
-270
-0.8% -$62.9K
THC icon
62
Tenet Healthcare
THC
$22.2B
$7.73M 0.32%
58,090
+36,770
+172% +$4.43M
RACE icon
63
Ferrari
RACE
$67.8B
$7.67M 0.31%
18,794
+690
+4% +$287K
JLL icon
64
Jones Lang LaSalle
JLL
$15.8B
$7.57M 0.31%
36,890
+3,460
+10% +$671K
MTDR icon
65
Matador Resources
MTDR
$6.04B
$7.57M 0.31%
127,050
+58,120
+84% +$3.65M
WIX icon
66
WIX.com
WIX
$2.56B
$7.47M 0.31%
46,960
-400
-0.8% -$57.5K
ACWX icon
67
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
$7.43M 0.3%
139,850
TTEK icon
68
Tetra Tech
TTEK
$8.77B
$7.36M 0.3%
179,850
-1,500
-0.8% -$61.1K
PNR icon
69
Pentair
PNR
$10.8B
$7.3M 0.3%
95,190
-18,850
-17% -$1.52M
CASY icon
70
Casey's General Stores
CASY
$32.1B
$7.28M 0.3%
19,080
-160
-0.8% -$53.4K
DELL icon
71
Dell
DELL
$239B
$7.17M 0.29%
51,990
+7,990
+18% +$1.07M
CLS icon
72
Celestica
CLS
$37.8B
$7.13M 0.29%
124,310
-71,040
-36% -$3.58M
VLO icon
73
Valero Energy
VLO
$89.5B
$7.08M 0.29%
45,160
-84,540
-65% -$13.6M
MOD icon
74
Modine Manufacturing
MOD
$9.46B
$6.91M 0.28%
68,980
-600
-0.9% -$57.6K
KBR icon
75
KBR
KBR
$4.56B
$6.88M 0.28%
+107,280
New +$6.93M

Similar funds

Castleark Management's Q2 2024 Portfolio in Review

As of Q2 2024, Castleark Management held 310 positions worth $2.45B, up 1.8% from $2.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Castleark Management withdrew a net $94.4M in Q2 2024, closing 39 positions and reducing 85 holdings. Its most notable exit was Las Vegas Sands, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Castleark Management opened a new position in Colgate-Palmolive worth $21.5M.

  • Castleark Management's largest Q2 2024 buy was Colgate-Palmolive: 221,053 shares worth $21.5M.
  • Castleark Management added most to Union Pacific in Q2 2024, an estimated $20.8M increase.
  • Castleark Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $29.4M.
  • Castleark Management fully exited Las Vegas Sands in Q2 2024, selling an estimated $21.8M.
  • Castleark Management's ten largest holdings make up 41% of its $2.45B portfolio in Q2 2024.
  • Castleark Management opened 32 new positions and closed 39 in Q2 2024.
  • Castleark Management's portfolio value rose 1.8% quarter-over-quarter to $2.45B.

Based on Castleark Management's 13F filing for Q2 2024, filed 14 Aug 2024.